JPWO2021132565A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021132565A5 JPWO2021132565A5 JP2021567672A JP2021567672A JPWO2021132565A5 JP WO2021132565 A5 JPWO2021132565 A5 JP WO2021132565A5 JP 2021567672 A JP2021567672 A JP 2021567672A JP 2021567672 A JP2021567672 A JP 2021567672A JP WO2021132565 A5 JPWO2021132565 A5 JP WO2021132565A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous suspension
- suspension composition
- composition according
- sirolimus
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025080159A JP2025111828A (ja) | 2019-12-26 | 2025-05-13 | シロリムスまたはその塩を含有する水性懸濁組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019237226 | 2019-12-26 | ||
| JP2019237226 | 2019-12-26 | ||
| PCT/JP2020/048738 WO2021132565A1 (ja) | 2019-12-26 | 2020-12-25 | シロリムスまたはその塩を含有する水性懸濁組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080159A Division JP2025111828A (ja) | 2019-12-26 | 2025-05-13 | シロリムスまたはその塩を含有する水性懸濁組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021132565A1 JPWO2021132565A1 (https=) | 2021-07-01 |
| JPWO2021132565A5 true JPWO2021132565A5 (https=) | 2023-09-11 |
| JP7682103B2 JP7682103B2 (ja) | 2025-05-23 |
Family
ID=76575568
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567672A Active JP7682103B2 (ja) | 2019-12-26 | 2020-12-25 | シロリムスまたはその塩を含有する水性懸濁組成物 |
| JP2025080159A Pending JP2025111828A (ja) | 2019-12-26 | 2025-05-13 | シロリムスまたはその塩を含有する水性懸濁組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080159A Pending JP2025111828A (ja) | 2019-12-26 | 2025-05-13 | シロリムスまたはその塩を含有する水性懸濁組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230055121A1 (https=) |
| EP (1) | EP4082544A4 (https=) |
| JP (2) | JP7682103B2 (https=) |
| KR (1) | KR20220122612A (https=) |
| CN (2) | CN118340726A (https=) |
| AU (1) | AU2020411442B2 (https=) |
| CA (1) | CA3162626A1 (https=) |
| TW (1) | TWI871406B (https=) |
| WO (1) | WO2021132565A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116942607A (zh) * | 2023-01-13 | 2023-10-27 | 杭州微致生物科技有限公司 | 一种西罗莫司混悬液 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA924953B (en) | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
| US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| ES2507078T3 (es) * | 2007-08-16 | 2014-10-14 | Santen Pharmaceutical Co., Ltd | Formulaciones de rapamicina para tratamiento de la degeneración macular relacionada con la edad |
| ES2667945T3 (es) | 2007-10-08 | 2018-05-16 | Aurinia Pharmaceuticals Inc. | Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR |
| CN105073112B (zh) | 2013-03-13 | 2017-12-29 | 参天制药株式会社 | 睑板腺功能障碍的治疗剂 |
| JP6279395B2 (ja) * | 2014-05-01 | 2018-02-14 | 東亜薬品株式会社 | ブリンゾラミド懸濁性点眼液組成物の製造方法 |
| CN105833344B (zh) * | 2016-04-26 | 2019-04-26 | 青岛慧生惠众生物科技有限公司 | 一种可注射水凝胶在制备眼内填充物中的应用 |
| CN106420607B (zh) | 2016-11-02 | 2019-06-28 | 北京诺康达医药科技股份有限公司 | 一种西罗莫司纳米混悬剂及其制备方法 |
| EP3565520B1 (en) * | 2017-01-06 | 2026-02-25 | Palvella Therapeutics, Inc. | Anhydrous compositions of mtor inhibitors and methods of use |
| CN107334734B (zh) | 2017-07-10 | 2020-03-17 | 浙江大学 | 一种西罗莫司或其衍生物的眼用制剂 |
| US20200261427A1 (en) * | 2019-02-20 | 2020-08-20 | Al Therapeutics, Inc. | Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders |
-
2020
- 2020-12-25 US US17/784,327 patent/US20230055121A1/en active Pending
- 2020-12-25 WO PCT/JP2020/048738 patent/WO2021132565A1/ja not_active Ceased
- 2020-12-25 CA CA3162626A patent/CA3162626A1/en active Pending
- 2020-12-25 JP JP2021567672A patent/JP7682103B2/ja active Active
- 2020-12-25 CN CN202410500671.8A patent/CN118340726A/zh active Pending
- 2020-12-25 EP EP20905210.9A patent/EP4082544A4/en active Pending
- 2020-12-25 AU AU2020411442A patent/AU2020411442B2/en active Active
- 2020-12-25 KR KR1020227018715A patent/KR20220122612A/ko not_active Ceased
- 2020-12-25 CN CN202080089390.8A patent/CN114845714B/zh active Active
- 2020-12-25 TW TW109146288A patent/TWI871406B/zh active
-
2025
- 2025-05-13 JP JP2025080159A patent/JP2025111828A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4968844B2 (ja) | 局所用ネパフェナク処方物 | |
| JP2018030871A (ja) | 非刺激性の眼科用ポビドンヨード組成物 | |
| JP6449205B2 (ja) | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 | |
| TWI605836B (zh) | Aqueous liquid | |
| JP4314433B2 (ja) | Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 | |
| TW201609097A (zh) | 含吡啶基胺基乙酸化合物之醫藥組成物 | |
| JPWO2021132565A5 (https=) | ||
| JP5246182B2 (ja) | 点眼剤、防腐剤及び防腐力向上剤 | |
| CN104224704A (zh) | 水性组合物 | |
| JP2014515383A5 (https=) | ||
| JP2004107335A (ja) | Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 | |
| JP4905616B2 (ja) | ソフトコンタクトレンズ用点眼剤 | |
| IL305997A (en) | Laquinimod formulation for ocular use | |
| JP2013181020A (ja) | 眼科用組成物 | |
| JP2003171276A (ja) | 眼精疲労改善眼科用組成物 | |
| JP2002322048A (ja) | ソフトコンタクトレンズ用組成物 | |
| JP6449774B2 (ja) | 両性イオン性ソフトコンタクトレンズ用眼科用組成物 | |
| JP5340498B1 (ja) | ソフトコンタクトレンズ用眼科用組成物 | |
| KR20220131878A (ko) | 세티리진 및 토코페솔란을 포함하는 안과용 조성물 | |
| JPWO2012099142A1 (ja) | 保存効力を有するブロムフェナク水性液剤組成物 | |
| CA2226348A1 (en) | Ophthalmic preparations | |
| JP2020524138A (ja) | 緑内障治療用点眼組成物 | |
| JP4933007B2 (ja) | 眼科組成物及び該組成物の抗菌力増強方法 | |
| JP2022503726A5 (https=) | ||
| TW201622700A (zh) | 水性醫藥組成物 |